- 4.8Impact Factor
- 9.2CiteScore
- 20 daysTime to First Decision
Biomolecules, Volume 8, Issue 1
March 2018 - 13 articles
Cover Story: The antibiotic crisis has led to a pressing need for alternatives such as antimicrobial peptides (AMPs). Antimicrobial peptides, also known as host defense peptides, have shown great promise given that the use of AMPs leads to no, or low, resistance developed by bacteria. We discuss the diversity, history and the various mechanisms of action of AMPs. Although many AMPs have been identified and characterized, not many have yet made it into clinical trials, and only a few have been approved by the US Food and Drug Administration (FDA) due to issues with toxicity, protease cleavage and rapid kidney clearance. Some of the recent strategies developed to address these issues, such as chemical modifications of AMPs and the use of delivery systems, are also reviewed in this article. View the paper here.
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Articles
There are no articles in this issue yet.
Get Alerted
Add your email address to receive forthcoming issues of this journal.
Biomolecules - ISSN 2218-273X